Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation

Onur Bender, Eman A. M. Beshr, Taha F. S. Ali et al.|Archiv der Pharmazie|2022

Cited by 19